Jeong-jin Seo officially retired, “It was an honor to be the chairman of Celltrion” As the eldest and second-son executive director
Jeong-Jin Seo “Unlimited supply of corona antibody therapy to domestic manufacturing costs… vaccine development”
Seo Jeong-jin “Responds to the mutation of Rekirona…Deriving phase 3 results within 5 months” (Comprehensive)